Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$177.23 - $227.44 $106,338 - $136,464
-600 Reduced 20.69%
2,300 $439,000
Q2 2022

Aug 15, 2022

BUY
$181.58 - $368.0 $90,790 - $184,000
500 Added 20.83%
2,900 $535,000
Q1 2022

May 16, 2022

BUY
$303.87 - $423.8 $182,322 - $254,280
600 Added 33.33%
2,400 $839,000
Q4 2021

Feb 14, 2022

SELL
$347.28 - $421.83 $972,383 - $1.18 Million
-2,800 Reduced 60.87%
1,800 $685,000
Q3 2021

Nov 15, 2021

SELL
$405.61 - $524.84 $121,683 - $157,452
-300 Reduced 6.12%
4,600 $1.87 Million
Q2 2021

Aug 16, 2021

SELL
$372.84 - $481.5 $74,568 - $96,300
-200 Reduced 3.92%
4,900 $2.32 Million
Q1 2021

May 17, 2021

BUY
$361.28 - $504.76 $1.84 Million - $2.57 Million
5,100 New
5,100 $1.96 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22.7B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.